A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

Clinical trial NCT02637037 · COMPLETED

Trial details

NCT number: NCT02637037
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Fixed Dose Combination Tablets Healthy Male and Female Subjects

Start date: 2015-12-21
Primary completion: 2016-04-07
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.